The Prognostic Role of LRIG Proteins in Endometrial CancerShow others and affiliations
2021 (English)In: Cancers, ISSN 2072-6694, Vol. 13, no 6, article id 1361Article in journal (Refereed) Published
Abstract [en]
Endometrial cancer (EC) is the most common gynecologic malignancy in Sweden and it has various prognostic factors. The LRIG family is a group of three integral surface proteins with a similar domain organization. The study aimed to explore LRIG family as prognostic factor proteins in EC. The initial study cohort included 100 women with EC who were treated at the Department of Women’s and Children’s Health, Karolinska University Hospital Solna, between 2007 and 2012. We assessed the associations between LRIG protein expression and type, grade, and stage of EC, as well as progression-free and overall survival. Immunohistochemistry results revealed that most women in the analytical sample had >50% LRIG1-, LRIG2- and LRIG3-positive cells. A statistically significant association was observed between having a high number of LRIG3-positive cells and superior overall survival (incidence rate ratio = 0.977; 95% confidence interval: 0.958–0.996, p = 0.019). Moreover, positive LRIG3 staining of the cell membrane was associated with reducing in the risk of death (hazard ratio = 0.23; 95% confidence interval: 0.09–0.57). Our results show that LRIG3 expression might be a prognostic factor in EC. The role of LRIG1 and LRIG2 expression remains to be further investigated.
Place, publisher, year, edition, pages
MDPI, 2021. Vol. 13, no 6, article id 1361
Keywords [en]
LRIG1, LRIG2, LRIG3, endometrial cancer, prognosis
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-90975DOI: 10.3390/cancers13061361ISI: 000634344300001PubMedID: 33802837Scopus ID: 2-s2.0-85102558250OAI: oai:DiVA.org:oru-90975DiVA, id: diva2:1543932
Funder
Swedish Society for Medical Research (SSMF)
Note
Funding Agency:
Cancer Research Foundation in Northern Sweden
2021-04-132021-04-132021-04-16Bibliographically approved